1. Home
  2. SHAK vs CELC Comparison

SHAK vs CELC Comparison

Compare SHAK & CELC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shake Shack Inc.

SHAK

Shake Shack Inc.

HOLD

Current Price

$88.85

Market Cap

3.5B

ML Signal

HOLD

Logo Celcuity Inc.

CELC

Celcuity Inc.

N/A

Current Price

$114.28

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHAK
CELC
Founded
2004
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.1B
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
SHAK
CELC
Price
$88.85
$114.28
Analyst Decision
Buy
Strong Buy
Analyst Count
25
8
Target Price
$115.65
$107.88
AVG Volume (30 Days)
1.1M
646.9K
Earning Date
04-30-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
354.17
N/A
EPS
1.09
N/A
Revenue
$1,445,306,000.00
N/A
Revenue This Year
$16.38
N/A
Revenue Next Year
$14.92
$706.83
P/E Ratio
$81.27
N/A
Revenue Growth
15.38
N/A
52 Week Low
$72.93
$7.58
52 Week High
$142.23
$120.32

Technical Indicators

Market Signals
Indicator
SHAK
CELC
Relative Strength Index (RSI) 48.44 55.02
Support Level $85.64 $99.38
Resistance Level $89.42 $117.27
Average True Range (ATR) 3.84 5.98
MACD -0.45 0.12
Stochastic Oscillator 58.04 76.41

Price Performance

Historical Comparison
SHAK
CELC

About SHAK Shake Shack Inc.

Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine, and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh-brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water. Geographically, the company generates the majority of its revenue from the United States.

About CELC Celcuity Inc.

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.

Share on Social Networks: